{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:40Z","timestamp":1792789720123,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant nos. 82072441, 81871783, and 81672176"],"award-info":[{"award-number":["Grant nos. 82072441, 81871783, and 81672176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Previous studies have shown anti-cancer and anti-inflammatory benefits of glucosamine. This study was performed to prospectively evaluate the association between glucosamine supplementation and the mortality of multiple cancers based on the UK Biobank cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 453,645 participants aged 38\u201373 who had no cancer at baseline were recruited between 2006 and 2010 and followed until March 2021. We used cox and poission proportional hazards models to explore the association between habitual use of glucosamine and cancer mortality. Subgroup analyses were conducted to understand the potential effect modifications of demographics, lifestyle factors, and health outcomes. Sensitivity analyses were performed to determine the robustness of the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the participants, 88,224 (19.4%) reported habitual glucosamine use at baseline. There were 9,366 cancer deaths during a median follow-up of 12.1 years, and we observed a significant association between the use of glucosamine and lower overall cancer mortality (HR = 0.95, 95% CI = 0.90\u20131.00, <jats:italic>p<\/jats:italic> &amp;lt; 0.05), kidney cancer (IRR = 0.68, 95% CI = 0.49\u20130.95, <jats:italic>p<\/jats:italic> &amp;lt; 0.05), lung cancer mortality (IRR = 0.84, 95% CI = 0.74\u20130.95, <jats:italic>p<\/jats:italic> &amp;lt; 0.05), and rectum cancer (IRR = 0.76, 95% CI = 0.59\u20130.98, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). Subgroup analysis showed that habitual glucosamine supplementation was correlated with lower overall cancer mortality among participants who were aged \u2265 60 years, male, current smoker, without high cholesterol and not obese. Sensitivity analysis showed that the results were stable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Habitual glucosamine use was significantly related to decreased overall cancer, kidney cancer, lung cancer, and rectum cancer mortality, based on data from the large-scale, nationwide, prospective UK Biobank cohort study.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2022.947818","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:57:58Z","timestamp":1667383078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Association between glucosamine use and cancer mortality: A large prospective cohort study"],"prefix":"10.3389","volume":"9","author":[{"given":"Jian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","article-title":"Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.","volume":"365","author":"Ma","year":"2019","journal-title":"BMJ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/dc19-1836","article-title":"Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in UK Biobank.","volume":"43","author":"Ma","year":"2020","journal-title":"Diabetes Care."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041540","article-title":"Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older.","volume":"7","author":"Sibbritt","year":"2012","journal-title":"PLoS One."},{"key":"B4","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: United States, 2002-2012.","volume":"79","author":"Clarke","year":"2015","journal-title":"Natl Health Stat Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/jpp\/rgaa032","article-title":"Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.","volume":"73","author":"Valinezhad","year":"2021","journal-title":"J Pharm Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1473-2165.2006.00277.x","article-title":"Glucosamine: an ingredient with skin and other benefits.","volume":"5","author":"Bissett","year":"2006","journal-title":"J Cosmet Dermatol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-017-0221-7","article-title":"Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0\/G1 phase.","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lfs.2016.03.028","article-title":"Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent.","volume":"152","author":"Dalirfardouei","year":"2016","journal-title":"Life Sci."},{"key":"B10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/annrheumdis-2020-217176","article-title":"Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study.","volume":"79","author":"Li","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01399-2021","article-title":"Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.","volume":"59","author":"Li","year":"2022","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2021.07.023","article-title":"Healthy sleep patterns and risk of incident arrhythmias.","volume":"78","author":"Li","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003767","article-title":"Obesity and the relation between joint exposure to ambient air pollutants and incident type 2 diabetes: a cohort study in UK Biobank.","volume":"18","author":"Li","year":"2021","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0455","article-title":"Replacement of sedentary behavior by various daily-life physical activities and structured exercises: genetic risk and incident type 2 diabetes.","author":"Li","year":"2021","journal-title":"Diabetes Care."},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/CIRCULATIONAHA.120.050792","article-title":"Adherence to a healthy sleep pattern and incident heart failure: a prospective study of 408 802 UK biobank participants.","volume":"143","author":"Li","year":"2021","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.7326\/M21-2977","article-title":"Association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality : a large prospective cohort study.","volume":"175","author":"Liu","year":"2022","journal-title":"Ann Intern Med."},{"key":"B17","year":"2010","journal-title":"Global Recommendations On Physical Activity For Health."},{"key":"B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5312\/wjo.v8.i1.1","article-title":"Glucosamine and chondroitin for the treatment of osteoarthritis.","volume":"8","author":"Vasiliadis","year":"2017","journal-title":"World J Orthop."},{"key":"B19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.carbpol.2014.04.102","article-title":"Anti-tumor properties of orally administered glucosamine and N-acetyl-D-glucosamine oligomers in a mouse model.","volume":"111","author":"Masuda","year":"2014","journal-title":"Carbohydr Polym."},{"key":"B20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tiv.2011.10.005","article-title":"Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: induction of the caspase-dependent apoptosis and down-regulation of HIF-1alpha.","volume":"26","author":"Jung","year":"2012","journal-title":"Toxicol In Vitro."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1315-6","article-title":"Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.","volume":"16","author":"Pohlig","year":"2016","journal-title":"BMC Complement Altern Med."},{"key":"B22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10654-012-9714-6","article-title":"Use of glucosamine and chondroitin in relation to mortality.","volume":"27","author":"Bell","year":"2012","journal-title":"Eur J Epidemiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10552-011-9806-8","article-title":"Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort.","volume":"22","author":"Brasky","year":"2011","journal-title":"Cancer Causes Control."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1159\/000488042","article-title":"Acetyl-glucosamine sensitizes non-small cell lung cancer cells to trail-induced apoptosis by activating death receptor 5.","volume":"45","author":"Liang","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/mmr.2012.918","article-title":"Chitooligosaccharides and N-acetyl-D-glucosamine stimulate peripheral blood mononuclear cell-mediated antitumor immune responses.","volume":"6","author":"Xu","year":"2012","journal-title":"Mol Med Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.3892\/mmr.2017.6976","article-title":"Antilung cancer effect of glucosamine by suppressing the phosphorylation of FOXO.","volume":"16","author":"Yu","year":"2017","journal-title":"Mol Med Rep."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.947818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:58:06Z","timestamp":1667383086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.947818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":26,"alternative-id":["10.3389\/fnut.2022.947818"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.947818","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"947818"}}